Innoquest Pathology-Rebranding and Dual Accreditation

Dr Nelson Nheu, CEO, Innoquest Pathology Sdn Bhd

The Marketplace · The Marketplace · 26 Sept 2022 · 1 mins listen

Earlier this year, Gribbles Pathology, a leading clinical lab testing service provider in Malaysia, undertook a rebranding exercise into Innoquest Pathology. We speak to Dr Nelson Nheu, CEO of Innoquest Pathology, on what this means for doctors and patients, and Gribbles' network of diagnostic labs. For our full range of accredited services, contact us today at: https://www.innoquest.com.my/contact/

Produced by:

none

Presented by:

none

Categories:

technology,wellness,medical advances

Tags:

Innoquest Pathology ,clinical,lab trial,rebranding

Related Content